Why pre-screen biomaterials engineers before the technical panel
Material behaviour in a body is a long game. Degradation products accumulate, mechanical properties change, and a response that looked acceptable at four weeks looks different at two years. Engineers worth hiring have run testing long enough to see something change and can describe what failed. A short screen asks for that, alongside the regulatory route they were working towards.
What actually matters when screening Biomaterials Engineer candidates
- 01
Technical depth
Probe depth in polymer and ceramic scaffold chemistry: degradation kinetics of PLGA or PCL, crosslinking control, and characterisation via DSC, FTIR, SEM, and mechanical testing per ASTM F2150.
- 02
Work that shipped
Ask which implants, hydrogels, coatings, or scaffolds reached bench validation, animal study, or 510(k) submission, and what their named contribution to the design history file was.
- 03
Diagnosis under uncertainty
Test how they chased failures: unexpected cytotoxicity, batch-to-batch variability in swelling ratio, delamination of coatings, or gamma sterilisation embrittlement. Look for structured root cause work.
- 04
Working across the org
Assess collaboration with cell biologists, quality and regulatory affairs, contract manufacturers, and surgeons; check how they handled design controls, risk files, and supplier change notices.
Pre-screening questions to ask Biomaterials Engineer candidates
12 questions grouped by what they test. Ask the same set in every screen and score answers on a consistent scale, or send them as an async video screen and compare answers side by side.
Materials they developed
3 questions01What kinds of materials have you worked with in previous roles?
Listen forSpecific material classes with the applications they were developed for, and their own contribution.
Material families listed without application, or work performed entirely by collaborators.
02Do you have experience developing and testing new materials for medical applications?
Listen forDevelopment from formulation through characterisation to testing, with the results including any failures.
Development described without characterisation data, or only successful results reported.
03Can you explain a project where you used biomaterials to solve a medical problem?
Listen forA clinical need stated first, with the material chosen for properties that address it specifically.
Material developed first and an application sought afterwards, or clinical need described vaguely.
Tested properly
4 questions04Do you have experience with laboratory and animal testing of biomaterials?
Listen forStudies with proper controls and sample numbers, run to recognised biocompatibility standards.
Testing without controls, or results reported from sample numbers too small to support them.
05Do you have experience with synthetic materials intended for implantation?
Listen forDegradation, wear particles and long-term host response all considered over realistic timescales.
Short-term results presented as evidence of long-term safety, or degradation products not studied.
06Can you discuss your experience with additive manufacturing of biomaterials?
Listen forProcess effects on material properties understood, with printed parts characterised not assumed.
Printed material assumed identical to bulk, or process parameters not linked to properties.
07Do you have experience with nanomaterials in this context?
Listen forAwareness that nanoscale materials raise different safety questions, with testing adapted accordingly.
Nanomaterials treated as ordinary materials, or particle release and toxicity not considered.
Regulatory path known
2 questions08How familiar are you with the regulatory requirements for biomaterials?
Listen forApplicable biocompatibility standards named, with the testing designed towards the intended device classification.
Regulation treated as a later stage, or studies run to a standard the regulator will not accept.
09Do you have experience taking a material from laboratory testing towards clinical use?
Listen forThe evidence chain understood, with manufacturing consistency treated as part of the requirement.
Translation described optimistically, or manufacturing scale-up not considered during development.
Records hold up
3 questions10Describe your experience working with interdisciplinary teams on these projects?
Listen forWork with clinicians and biologists shaping requirements, with their input changing material choices.
Clinical input sought only at testing, or requirements written without external consultation.
11What is your method for maintaining accurate research documentation?
Listen forContemporaneous records with batch details and parameters, complete enough for another person to repeat.
Records reconstructed later, or material batches not traceable to the results they produced.
12Which software tools do you use in your biomaterials work?
Listen forAnalysis and modelling tools used competently, with data processing steps recorded and repeatable.
Analysis performed manually without record, or processing steps that cannot be reproduced.
How to score responses
Score every candidate on the same four criteria immediately after the screen. At this stage you are shortlisting for panel interviews, not making the final call.
Technical depth
35%5Explains material selection through degradation rate, modulus matching, and sterilisation effects, citing specific characterisation data they generated themselves.
Work that shipped
30%5Names shipped devices or transferred processes with batch volumes, ISO 10993 biocompatibility outcomes, and regulatory milestones they personally supported.
Diagnosis under uncertainty
20%5Walks through a real failure with hypotheses ranked, DOE or ageing studies run, and the material or process change that resolved it.
Working across the org
15%5Describes concrete handoffs to QA, clinicians, and CMOs, including specification negotiations and how conflicting constraints were resolved.
A response that looks fine at four weeks can look different at two years. A one-way video screen asks what failed.
Try it on HirevireScreening FAQ
Process basics
How long should a pre-screening round for this role take?
Fifteen minutes across eight to ten questions, answered async. Enough to establish materials they developed, test their characterisation and testing depth, and check regulatory experience.
How much regulatory experience should I expect?
Enough to know what evidence the intended use requires and to design testing towards it. An engineer who treats that as later work will repeat studies that were run to the wrong standard.
Evaluating answers
What is the strongest signal when screening this role?
Something that failed in long-term testing. Engineers with real development experience have one and can explain the mechanism. Anyone reporting only successful results has not tested long enough.
How do I judge their testing rigour?
Ask about controls in their biological testing. Real answers cover positive and negative controls and sample numbers. Anything less will not be accepted by a reviewer or a journal.
Go deeper on this role
Sanat has been hiring since 2012 and watching the recruitment industry change up close ever since, and turned that screening process into Hirevire's video screening platform. LinkedIn
